Home/Filings/4/0001725160-24-000143
4//SEC Filing

Kariuki Enoch 4

Accession 0001725160-24-000143

CIK 0001725160other

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 5:09 PM ET

Size

355.4 KB

Accession

0001725160-24-000143

Insider Transaction Report

Form 4
Period: 2024-06-21
Transactions
  • Award

    Common Stock

    2024-06-21+41,58179,762 total
Footnotes (1)
  • [F1]Represents restricted stock units granted pursuant to the Issuer's Non-Employee Director Compensation Program, each of which represents a contingent right to receive one share of common stock, and which will vest on the first to occur of (a) June 21, 2025 or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date.

Issuer

Zentalis Pharmaceuticals, Inc.

CIK 0001725160

Entity typeother

Related Parties

1
  • filerCIK 0001843119

Filing Metadata

Form type
4
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 5:09 PM ET
Size
355.4 KB